PAI Holdings, LLC (Pharmaceutical Associates Inc) is recalling approximately 1,477 cases of three different liquid prescription medications: Nystatin Oral Suspension, Cimetidine Hydrochloride Oral Solution, and Ethosuximide Oral Solution. The recall was initiated because the products may have been contaminated with Senna Syrup during the manufacturing process due to a lack of current Good Manufacturing Practices (CGMP). These medications are used to treat fungal infections, stomach acid issues, and seizures, respectively.
The medications may contain carry-over traces of Senna Syrup, a laxative, which was not intended to be in these formulations. This cross-contamination can lead to unexpected side effects or reduced effectiveness of the prescribed treatment.
Contact healthcare provider and return to pharmacy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.